PBP received a daily buy-back notice
On 3 December 2018, Probiotec Limited (ASX: PBP) receives a daily share buy-back notice from ASX. The notice contains the information about the buy-back. The buy-back type is on market buy-back where 01 November 2018 was the date given as per Appendix 3C to the ASX. The number of shares that are bought back based on the acceptance that is received the previous day was 29,450 shares and before the previous day was 450,799 shares. The consideration paid for the buy-back on the previous day’s 29,450 shares was $43,891.
If the type of the buy-back is on-market buy-back, then the highest price paid will be $1.495 and the lowest price paid was $1.490. The highest price allowed is based under 7.33: $1.57. Similarly, the day before the previous day, the highest price paid was $1.50 as on 23 November 2018 and the lowest price was $1.42 as on 20 November 2018. The remaining number of shares that need to buy-back is 5,902,686 shares.
The company has maintained a positive performance since its inception to last six months. Since its inception, the performance of the company is 14.22%. In the ten years of duration, the performance of the company is 14.22%. If we see the last five years, the performance of the company was 258.59%. Since last year, the performance of the company is 120.27%. However, since the last three months, the performance of the company is negative. The performance of the company in 3 months was -6.55%.
With the market open, the share price was A$1.490. It went as high as A$1.495. The lowest price recorded for the day was A$1.480 and the last traded price was A$1.490 with the stock having a market capitalization of A$95.11 million. This price movement almost appears to be flat as per the chart.
Prana Biotechnology Limited (ASX: PBT)
With the market open, the share price of Prana Biotechnology Limited (ASX: PBT) increased by 5.405% which is towards the lower end of the 52 weeks low price. The opening price of the share was A$0.038. It went as high as A$0.039. The lowest price recorded for the day was A$0.038. The last traded price of the share was A$0.039 with the stock having market capitalization of A$19.87 million.
It is not only the performance of the company which has led to an increase in the share price of the company. The possible reason might be that there is an increase in the S&P/ASX 200 Health Care (Sector) by 2.56%. If we observe the chart pattern, there are frequent instances where the trades have traded flat which indicates the uncertainty in the market. Uncertainty in the market means that the share price may either go up or down. As per the graph, the status of the stock is to wait and watch the upcoming price movement.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.